385 related articles for article (PubMed ID: 10340686)
1. Does loxapine have "atypical" properties? Clinical evidence.
Glazer WM
J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
[TBL] [Abstract][Full Text] [Related]
2. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.
Singh AN; Barlas C; Singh S; Franks P; Mishra RK
J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic.
Ereshefsky L
J Clin Psychiatry; 1999; 60 Suppl 10():20-30. PubMed ID: 10340684
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
Haleem DJ
J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
[TBL] [Abstract][Full Text] [Related]
6. Do loxapine plus cyproheptadine make an atypical antipsychotic? PET analysis of their dopamine D2 and serotonin2 receptor occupancy.
Kapur S; Zipursky RB
Arch Gen Psychiatry; 1998 Jul; 55(7):666-8. PubMed ID: 9672060
[No Abstract] [Full Text] [Related]
7. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
Singh AN; Barlas C; Saeedi H; Mishra RK
J Psychiatry Neurosci; 2003 Jan; 28(1):39-47. PubMed ID: 12587849
[TBL] [Abstract][Full Text] [Related]
8. Introduction: What makes an antipsychotic atypical?
Stahl SM
J Clin Psychiatry; 1999; 60 Suppl 10():3-4. PubMed ID: 10340681
[No Abstract] [Full Text] [Related]
9. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
10. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus novel antipsychotics: changing concepts and clinical implications.
Remington G; Chong SA
J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
[TBL] [Abstract][Full Text] [Related]
12. Loxapine update: 1966-1976.
Ayd FJ
Dis Nerv Syst; 1977 Nov; 38(11):883-7. PubMed ID: 410614
[No Abstract] [Full Text] [Related]
13. Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?
Meltzer HY; Jayathilake K
J Clin Psychiatry; 1999; 60 Suppl 10():47-51. PubMed ID: 10340687
[TBL] [Abstract][Full Text] [Related]
14. Psychosis in elderly patients: classification and pharmacotherapy.
Mintzer J; Targum SD
J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
[TBL] [Abstract][Full Text] [Related]
15. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
Remington G; Kapur S
J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
Keck PE; McElroy SL; Strakowski SM; Soutullo CA
J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
[TBL] [Abstract][Full Text] [Related]
17. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Tuason VB; Escobar JI; Garvey M; Schiele B
J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
[TBL] [Abstract][Full Text] [Related]
18. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
Nasrallah HA; Tandon R
J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
[TBL] [Abstract][Full Text] [Related]
20. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
Sokolski KN
Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
